Podcast: The FDA’s GenAI proposal: evolving regulation for an evolved medtech era

A Morgan Lewis partner discusses the FDA's recently released discussion paper on regulating generative AI in medical technology. The conversation covers the agency's proposed framework for oversight of GenAI-based devices, including potential pathways for clearance and post-market monitoring, as the FDA shapes regulatory strategy around AI-driven medical tools.